HomeACADEMIA
ACADEMIA

Hepatology Society to Release Updated Hep C Guidelines Soon, Reflecting Ximency Use
(Mar.3.2017)

The Japan Society of Hepatology plans to shortly announce an updated version of its hepatitis C treatment guidelines, which will reflect the use of Bristol-Myers Squibb’s triple direct-acting antiviral combo Ximency (daclatasvir + asunaprevir + beclabuvir) ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar